Re: BETonMACE Placebo Estimate
in response to
by
posted on
Feb 20, 2019 07:11PM
Tada, I remember that period and the brief glee and subsequent shock that RVX shareholders went through as the Assure trial fell short of target. It could be considered a cautionary tale for newer shareholders. Within a few hours RVX shares fell from close to $ 30.00per share to 15 cents. One day it was the most heavily traded stock on the TSX. There was a lot of speculation around RVX and Don pumped it up ( he has learned a lesson from the experience. ) Fortunatly I put in a stop loss on all my RVX shares - l was getting concerned about being invested in such a small company with very little cash on hand and almost completely unknown outside of Calgary. At the end of May 2013 Don spun off Zenith which included roylaty shares accruing to the existing shareholders. A shareholders meeting was held in Downtown Calgary to approve the issuance of those shares and evething seemed fine. The Assure trial was coming to the end and expectations were runing high. Don brought Dr. Stephan Nichols of the Cleveland Clinic to present. Don was in his glory and had visions of taking RVX into the big time. At the Q and A I asked Don " If Pfizer bought Esperion for $ 1.3B would you take the same for RVX. His reply was jokingly ( I think ) " Only if it was my share
This is my little retropesctive and I think Don has done a terrific job and I think he will take us to the promised land. He might even get that $1.3B So I am late with my prediction of a buyout price. I say $ 25.00 per share before September though I would be happy for anything over $ 10.